Correlation Between NeuroSense Therapeutics and Nexgel

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Nexgel at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Nexgel into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Nexgel Inc, you can compare the effects of market volatilities on NeuroSense Therapeutics and Nexgel and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Nexgel. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Nexgel.

Diversification Opportunities for NeuroSense Therapeutics and Nexgel

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between NeuroSense and Nexgel is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Nexgel Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexgel Inc and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Nexgel. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexgel Inc has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Nexgel go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and Nexgel

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 5.17 times more return on investment than Nexgel. However, NeuroSense Therapeutics is 5.17 times more volatile than Nexgel Inc. It trades about 0.19 of its potential returns per unit of risk. Nexgel Inc is currently generating about 0.22 per unit of risk. If you would invest  36.00  in NeuroSense Therapeutics Ltd on October 4, 2024 and sell it today you would earn a total of  8.00  from holding NeuroSense Therapeutics Ltd or generate 22.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy85.71%
ValuesDaily Returns

NeuroSense Therapeutics Ltd  vs.  Nexgel Inc

 Performance 
       Timeline  
NeuroSense Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Nexgel Inc 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Nexgel Inc are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting technical and fundamental indicators, Nexgel disclosed solid returns over the last few months and may actually be approaching a breakup point.

NeuroSense Therapeutics and Nexgel Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NeuroSense Therapeutics and Nexgel

The main advantage of trading using opposite NeuroSense Therapeutics and Nexgel positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Nexgel can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexgel will offset losses from the drop in Nexgel's long position.
The idea behind NeuroSense Therapeutics Ltd and Nexgel Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stocks Directory
Find actively traded stocks across global markets